Gene · 3663
Papers4,211
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
961 to 980 of 4,211
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The m6A/m5C/m1A Regulated Gene Signature Predicts the Prognosis and Correlates With the Immune Status of Hepatocellular Carcinoma. | Front Immunol | 2022 | 35833147 | PubTator, text mining | PubMed |
| Lack of Association Between Sex Hormones, MDSCs, LDGs and pDCs in Males and Females With Systemic Lupus Erythematosus. | Front Immunol | 2022 | 35833144 | PubTator, text mining | PubMed |
| Retinal drusen counts are increased in inflammatory bowel disease, and with longer disease duration, more complications and associated IgA glomerulonephritis. | Sci Rep | 2022 | 35817816 | PubTator, text mining | PubMed |
| CLEC10A can serve as a potential therapeutic target and its level correlates with immune infiltration in breast cancer. | Oncol Lett | 2022 | 35814828 | PubTator, text mining | PubMed |
| Identification of CFHR4 as a Potential Prognosis Biomarker Associated With lmmune Infiltrates in Hepatocellular Carcinoma. | Front Immunol | 2022 | 35812416 | PubTator, text mining | PubMed |
| DNA methylation and transcriptional profiles of IRF5 gene in ankylosing spondylitis: A case-control study. | Int Immunopharmacol | 2022 | 35810492 | PubTator, text mining | PubMed |
| Are Alterations in DNA Methylation Related to CKD Development? | Int J Mol Sci | 2022 | 35806113 | PubTator, text mining | PubMed |
| Thrombosis and Anticoagulation Therapy in Systemic Lupus Erythematosus. | Autoimmune Dis | 2022 | 35795725 | PubTator, text mining | PubMed |
| Identification of COL1A1 associated with immune infiltration in brain lower grade glioma. | PLoS One | 2022 | 35789341 | PubTator, text mining | PubMed |
| The NCF1 variant p.R90H aggravates autoimmunity by facilitating the activation of plasmacytoid dendritic cells. | J Clin Invest | 2022 | 35788118 | PubTator, text mining | PubMed |
| Lighting a Fire: Gasdermin-Mediated Pyroptosis Remodels the Glioma Microenvironment and Promotes Immune Checkpoint Blockade Response. | Front Immunol | 2022 | 35784306 | PubTator, text mining | PubMed |
| Curcumin as an effective suppressor of miRNA expression in patients with knee osteoarthritis. | Avicenna J Phytomed | 2022 | 35782767 | PubTator, text mining | PubMed |
| Performance of the Revised Classification Criteria for Systemic Autoimmune Rheumatic Diseases and Their Overlap Syndromes. | Intern Med | 2022 | 35781270 | PubTator, text mining | PubMed |
| Epigenetic and Transcriptomic Regulation Landscape in HPV+ Cancers: Biological and Clinical Implications. | Front Genet | 2022 | 35774512 | PubTator, text mining | PubMed |
| Exonuclease 1 is a Potential Diagnostic and Prognostic Biomarker in Hepatocellular Carcinoma. | Front Mol Biosci | 2022 | 35769911 | PubTator, text mining | PubMed |
| Early IFNβ secretion determines variable downstream IL-12p70 responses upon TLR4 activation. | Cell Rep | 2022 | 35767946 | PubTator, text mining | PubMed |
| Changes Within H3K4me3-Marked Histone Reveal Molecular Background of Neutrophil Functional Plasticity. | Front Immunol | 2022 | 35757755 | PubTator, text mining | PubMed |
| Identification of the Potential Correlation between Tumor Protein 73 and Head and Neck Squamous Cell Carcinoma. | Dis Markers | 2022 | 35756491 | PubTator, text mining | PubMed |
| Prognostic and Immunological Value of GNB4 in Gastric Cancer by Analyzing TCGA Database. | Dis Markers | 2022 | 35756485 | PubTator, text mining | PubMed |
| CTHRC1 is a Potential Prognostic Biomarker and Correlated with Macrophage Infiltration in Breast Cancer. | Int J Gen Med | 2022 | 35755862 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3663/papers?page=49